炎症与动脉粥样硬化关系研究进展(3)
| 第1页 |
参见附件(741KB，5页)。
[8]Pence S，Yilmaz G，Yilmaz N， et a1 Determination of plasma fibronectin and seHlm C-reactive protein in patients with cerebrovascular events Int J Clin Pract，2003，57：91-95
[9]Willerson JT，Ridkre PM Inflammation as a cardiovascular risk factor Circuiation，2004，109(21 Suppl 1)：2-10
[10]Curb JD Abbott RD Rodriguez BL, et a1 C-reactive protein and the future risk of thromboembolic stroke in healthy menCirculation 2003,107：2016 -2020
[11] Bachmaier K Neu N Maza LM et a1 Ohmamydia infections and heart disease linked through antighnicmicryScience， 1999，283：1335 -1339
[12]Mach F，Schonbeck U，Sukhow GK, et a1 Functional CD40 ligand is expressed on human vascular endothelial cells， smooth muscle cells，and macrophages Implication for：CD4-CD40 ligand signaling in atherosclerosis Proc Natl Acad Sci USA, 1997，94：1931-1936
[13] Gidron Y，Gilutz H，Bcrger R，et a1 Molecular and cellular interface between behavior and acute coronary syndromesCardiovascular Research, 2002,56：15 -21
[14] Ada Y，Asahina A，Nakamura K Transforming growth factor-beta up-regulates CD40-engaged IL-1 2 production of mouse Langerhans cells Eur J Immunol，2001, 31：294-300
[15]Arturo Garcia-Touchard，Timothy DHenry，Giuseppe Sangiorgi，et alExtracellular Proteases in Atherosclerosis and RestenosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005,25:1119
[16] Guo-Ping Shi，Galina KSukhova， Anders Grubb， et alCystatin C deficiency in human atherosclerosis and aortic aneurysmsJ Clin Invest, 1999, 104: 1191-1197
[17] Sacks FM，Pfefer MA，Moye LA，et al The effect of pravastation on coronary events after myocardial infarction in patients with average cholesteroIlevels N Engl J Med, 1996, 335：1001-1009
[18] The Long-Term Intervention with Pm、astatin in Ischaemic Disease (LIPID)Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad rangeofinitial cholesterol levels N Engl J Med,1998, 339：1349-1357
[19] Wmi-dms JK, Sukhova GK, Herrington DM, et a1 Pravastatin has cholesterol lowering independent effects on the artery wall of atherosclerotic monkeys Am J Coil Cardio1, 1998, 31：684 -691
[20] Schiefer B，Schiefief E，Hilfiker-K1iner D，et a1 Expression of allgiotensin Ⅱ and interleukin 6 in human coronary atherosclerotic plaques Circulation, 2000，101：1372 -1378
[21]Pepys MB，Berger A The renaissance of C-reactive proteinJ BMJ 2001,322：4 -5
(收稿日期 2006-04-16)(编辑 艾 拓)
[ 上 页 ]
您现在查看是摘要介绍页，详见PDF附件(741KB，5页)。